|
1
|
Collisson EA, Campbell JD, Brooks AN,
Berger AH, Lee W, Chmielecki J, Beer DG, Cope L, Creighton CJ,
Danilova L, et al: Comprehensive molecular profiling of lung
adenocarcinoma: The cancer genome atlas research network. Nature.
511:543–550. 2014. View Article : Google Scholar
|
|
2
|
Chen P, Liu Y, Wen Y and Zhou C: Non-small
cell lung cancer in China. Cancer Commun (Lond). 42:937–970. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zulfiqar B, Farooq A, Kanwal S and Asghar
K: Immunotherapy and targeted therapy for lung cancer: Current
status and future perspectives. Front Pharmacol. 13:10351712022.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Herbst RS, Morgensztern D and Boshoff C:
The biology and management of non-small cell lung cancer. Nature.
553:446–454. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Denisenko TV, Budkevich IN and Zhivotovsky
B: Cell death-based treatment of lung adenocarcinoma. Cell Death
Dis. 9:1172018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hooper C and Hilliker A: Packing them up
and dusting them off: RNA helicases and mRNA storage. Biochim
Biophys Acta. 1829:824–834. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Linder P and Jankowsky E: From unwinding
to clamping-the DEAD box RNA helicase family. Nat Rev Mol Cell
Biol. 12:505–516. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Owttrim GW: RNA helicases: Diverse roles
in prokaryotic response to abiotic stress. RNA Biol. 10:96–110.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Robert F and Pelletier J: Perturbations of
RNA helicases in cancer. Wiley Interdiscip Rev RNA. 4:333–349.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Steimer L and Klostermeier D: RNA
helicases in infection and disease. RNA Biol. 9:751–771. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Abdelhaleem M, Maltais L and Wain H: The
human DDX and DHX gene families of putative RNA helicases.
Genomics. 81:618–622. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Will CL, Urlaub H, Achsel T, Gentzel M,
Wilm M and Lührmann R: Characterization of novel SF3b and 17S U2
snRNP proteins, including a human Prp5p homologue and an SF3b
DEAD-box protein. EMBO J. 21:4978–4988. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li B, Li YM, He WT, Chen H, Zhu HW, Liu T,
Zhang JH, Song TN and Zhou YL: Knockdown of DDX46 inhibits
proliferation and induces apoptosis in esophageal squamous cell
carcinoma cells. Oncol Rep. 36:223–230. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jiang F, Zhang D, Li G and Wang X:
Knockdown of DDX46 inhibits the invasion and tumorigenesis in
osteosarcoma cells. Oncol Res. 25:417–25. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen L, Xu M, Zhong W, Hu Y and Wang G:
Knockdown of DDX46 suppresses the proliferation and invasion of
gastric cancer through inactivating Akt/GSK-3β/β-catenin pathway.
Exp Cell Res. 399:1124482021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Z, Jensen MA and Zenklusen JC: A
practical guide to the cancer genome atlas (TCGA). Methods Mol
Biol. 1418:111–141. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zheng M, Liu J, Bian T, Liu L, Sun H, Zhou
H, Zhao C, Yang Z, Shi J and Liu Y: Correlation between prognostic
indicator AHNAK2 and immune infiltrates in lung adenocarcinoma. Int
Immunopharmacol. 90:1071342021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun D, Wang J, Han Y, Dong X, Ge J, Zheng
R, Shi X, Wang B, Li Z, Ren P, et al: TISCH: A comprehensive web
resource enabling interactive single-cell transcriptome
visualization of tumor microenvironment. Nucleic Acids Res. 49(D1):
D1420–D1430. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lei Y, Zhou B, Meng X, Liang M, Song W,
Liang Y, Gao Y and Wang M: A risk score model based on lipid
metabolism-related genes could predict response to immunotherapy
and prognosis of lung adenocarcinoma: A multi-dataset study and
cytological validation. Discov Oncol. 14:1882023. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ru B, Wong CN, Tong Y, Zhong JY, Zhong
SSW, Wu WC, Chu KC, Wong CY, Lau CY, Chen I, et al: TISIDB: An
integrated repository portal for tumor-immune system interactions.
Bioinformatics. 35:4200–4202. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Komuro H, Shinohara S, Fukushima Y,
Demachi-Okamura A, Muraoka D, Masago K, Matsui T, Sugita Y,
Takahashi Y, Nishida R, et al: Single-cell sequencing on
CD8+ TILs revealed the nature of exhausted T cells
recognizing neoantigen and cancer/testis antigen in non-small cell
lung cancer. J Immunother Cancer. 11:e0071802023. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang W, Soares J, Greninger P, Edelman EJ,
Lightfoot H, Forbes S, Bindal N, Beare D, Smith JA, Thompson IR, et
al: Genomics of drug sensitivity in cancer (GDSC): A resource for
therapeutic biomarker discovery in cancer cells. Nucleic Acids Res.
41((Database Issue)): D955–D961. 2013.PubMed/NCBI
|
|
24
|
Li M, Ma Y, Huang P, Du A, Yang X, Zhang
S, Xing C, Liu F and Cao J: Lentiviral DDX46 knockdown inhibits
growth and induces apoptosis in human colorectal cancer cells.
Gene. 560:237–244. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ma Z, Song J, Hua Y, Wang Y, Cao W, Wang H
and Hou L: The role of DDX46 in breast cancer proliferation and
invasiveness: A potential therapeutic target. Cell Biol Int.
47:283–291. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Admoni-Elisha L, Nakdimon I, Shteinfer A,
Prezma T, Arif T, Arbel N, Melkov A, Zelichov O, Levi I and
Shoshan-Barmatz V: Novel biomarker proteins in chronic lymphocytic
leukemia: Impact on diagnosis, prognosis and treatment. PLoS One.
11:e01485002016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lin Q, Jin HJ, Zhang D and Gao L: DDX46
silencing inhibits cell proliferation by activating apoptosis and
autophagy in cutaneous squamous cell carcinoma. Mol Med Rep.
22:4236–4242. 2020.PubMed/NCBI
|
|
28
|
Zhang C, Kuang M, Li M, Feng L, Zhang K
and Cheng S: SMC4, which is essentially involved in lung
development, is associated with lung adenocarcinoma progression.
Sci Rep. 6:345082016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ma J, Gao Z and Liu X: DDX46 accelerates
the proliferation of glioblastoma by activating the MAPK-p38
signaling. J BUON. 26:2084–2089. 2021.PubMed/NCBI
|
|
30
|
You X, Cui H, Yu N and Li Q: Knockdown of
DDX46 inhibits trophoblast cell proliferation and migration through
the PI3K/Akt/mTOR signaling pathway in preeclampsia. Open Life Sci.
15:400–408. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Disoma C, Zhou Y, Li S, Peng J and Xia Z:
Wnt/β-catenin signaling in colorectal cancer: Is therapeutic
targeting even possible? Biochimie. 195:39–53. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wan C, Mahara S, Sun C, Doan A, Chua HK,
Xu D, Bian J, Li Y, Zhu D, Sooraj D, et al: Genome-scale
CRISPR-Cas9 screen of Wnt/β-catenin signaling identifies
therapeutic targets for colorectal cancer. Sci Adv. 7:eabf25672021.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhan T, Rindtorff N and Boutros M: Wnt
signaling in cancer. Oncogene. 36:1461–1473. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hankey W, Frankel WL and Groden J:
Functions of the APC tumor suppressor protein dependent and
independent of canonical WNT signaling: Implications for
therapeutic targeting. Cancer Metastasis Rev. 37:159–172. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bai R, Yin P, Xing Z, Wu S, Zhang W, Ma X,
Gan X, Liang Y, Zang Q, Lei H, et al: Investigation of GPR143 as a
promising novel marker for the progression of skin cutaneous
melanoma through bioinformatic analyses and cell experiments.
Apoptosis. 29:372–392. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ino Y, Yamazaki-Itoh R, Shimada K, Iwasaki
M, Kosuge T, Kanai Y and Hiraoka N: Immune cell infiltration as an
indicator of the immune microenvironment of pancreatic cancer. Br J
Cancer. 108:914–923. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Schneider K, Marbaix E, Bouzin C, Hamoir
M, Mahy P, Bol V and Gregoire V: Immune cell infiltration in head
and neck squamous cell carcinoma and patient outcome: A
retrospective study. Acta Oncol. 57:1165–1172. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Franciszkiewicz K, Boissonnas A, Boutet M,
Combadiere C and Mami-Chouaib F: Role of chemokines and chemokine
receptors in shaping the effector phase of the antitumor immune
response. Cancer Res. 72:6325–6332. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Koizumi K, Hojo S, Akashi T, Yasumoto K
and Saiki I: Chemokine receptors in cancer metastasis and cancer
cell-derived chemokines in host immune response. Cancer Sci.
98:1652–1658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hirth A, Fatti E, Netz E, Acebron SP,
Papageorgiou D, Švorinić A, Cruciat CM, Karaulanov E, Gopanenko A,
Zhu T, et al: DEAD box RNA helicases are pervasive protein kinase
interactors and activators. Genome Res. 34:952–966. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Shariati M and Meric-Bernstam F: Targeting
AKT for cancer therapy. Expert Opin Investig Drugs. 28:977–988.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wu SG and Shih JY: Management of acquired
resistance to EGFR TKI-targeted therapy in advanced non-small cell
lung cancer. Mol Cancer. 17:382018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wu CH, Lin KH, Fu BS, Hsu FT, Tsai JJ,
Weng MC and Pan PJ: Sorafenib induces apoptosis and inhibits
NF-κB-mediated anti-apoptotic and metastatic potential in
osteosarcoma cells. Anticancer Res. 41:1251–1259. 2021. View Article : Google Scholar : PubMed/NCBI
|
